Peptide Epoxide Carfilzomib - Request Quote
Peptide Epoxide Carfilzomib
| SZ CAT No: | SZ-C070023 |
| CAS No | NA |
| Mol.F. | C34H48N4O5 |
| Mol.Wt. | 592.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Peptide Epoxide Carfilzomib is chemically (2S)-2-((S)-2-Amino-4-phenylbutanamido)-4-methyl-N-((2S)-1-(((2R)-4-methyl-1-(2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)pentanamide. Peptide Epoxide Carfilzomib is supplied with detailed characterization data compliant with regulatory guideline. Peptide Epoxide Carfilzomib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Carfilzomib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Peptide Epoxide Carfilzomib
Purchase Peptide Epoxide Carfilzomib
Peptide Epoxide Carfilzomib suppliers
Peptide Epoxide Carfilzomib manufacturers
Peptide Epoxide Carfilzomib price
Order Peptide Epoxide Carfilzomib
Enquire Peptide Epoxide Carfilzomib
Peptide Epoxide Carfilzomib cost
Peptide Epoxide Carfilzomib Supplier
Peptide Epoxide Carfilzomib Distributor
Peptide Epoxide Carfilzomib for Method Validation
Carfilzomib Reference Standard
Peptide Epoxide Carfilzomib for ANDA Filing
Peptide Epoxide Carfilzomib for Forced Degradation Studies
Peptide Epoxide Carfilzomib Identification Standards
Peptide Epoxide Carfilzomib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.